대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

합성의약품으로 호전되지 않은 소화기 증상 환자(KCD K-코드)에 대한 반하사심탕 제제 병용의 효과 : 후향적 차트 분석

Effectiveness of Additional Administration of a Banha-sasim-tang Formulation to Patients with Gastrointestinal Symptoms (KCD K-code) Not Improved by Western Medicines: A Retrospective Chart Review

  • 김철현 (원광대학교 광주한방병원 한방내과) ;
  • 김광호 (원광대학교 광주한방병원 한방내과) ;
  • 이영웅 (원광대학교 광주한방병원 한방내과) ;
  • 강선이 (원광대학교 광주한방병원 한방내과) ;
  • 강건희 (원광대학교 한의과대학 순환신경내과학교실)
  • Kim, Cheol-hyun (Dept. of Korean Internal Medicine, Wonkwang University Gwangju Medical Center) ;
  • Kim, Kwangho (Dept. of Korean Internal Medicine, Wonkwang University Gwangju Medical Center) ;
  • Lee, Young-ung (Dept. of Korean Internal Medicine, Wonkwang University Gwangju Medical Center) ;
  • Kang, Sunny (Dept. of Korean Internal Medicine, Wonkwang University Gwangju Medical Center) ;
  • Kang, Geonhui (Dept. of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University)
  • 투고 : 2021.11.29
  • 심사 : 2021.12.29
  • 발행 : 2021.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: The aim of this study was to evaluate the effectiveness of additional administration of Banha-sasim-tang formulation to patients with gastrointestinal symptoms that did not improve with Western medicines. Methods: The patients who met the inclusion and exclusion criteria were analyzed retrospectively. A paired t-test was performed on the Nepean Dyspepsia Index-Korean version (NDI-K) scores before and after administering the Banha-sasim-tang formulation. Results: A total of 27 subjects were included. The mean duration of taking the Banha-sasim-tang formulation was 15.6±3.1 days. The most commonly used Western medicine before taking the Banha-sasim-tang formulation was rebamipide. The means of the NDI-K score were 57.4±21.8 before administering Banha-sasim-tang formulation and 34.9±16.5 after administration, and the difference was statistically significant (p<0.0001). No serious side effects were encountered while taking the Banha-sasim-tang formulation. Conclusions: For patients whose gastrointestinal symptoms do not improve with Western medicines, additional administration of Banha-sasim-tang formulation may be an option. However, as this study is a retrospective chart review, prospective, large-scale, double-blind studies are needed in the future.

키워드

과제정보

이 논문은 (주)제일한방의 지원에 의하여 수행되었음.

참고문헌

  1. Yoon SH, Ryu BH, Ryu KW, Kim JS. Evaluation for therapeutic effectiveness of Banwhasashim-tang in functional dyspepsia. J Int Korean Med 2003;24(2):329-36.
  2. Park JW, Ryu BH, Yeo IK, Jerng UM, Han GJ, Oh SH, et al. Banha-sasim-tang as an herbal formula for the treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled, two-center trial. Trials 2010;11(1):1-7. https://doi.org/10.1186/1745-6215-11-1
  3. Xu G. Treatment of reflux laryngopharyngitis with modified banxia xiexin tang (Pinellia decoction for draining the heart)--a report of 40 cases. Journal of traditional Chinese medicine=Chung i tsa chih ying wen pan 2006;26(2):127-31.
  4. Shin MR, An HJ, Seo BI, Roh SS. Anti-apoptotic effect of banhasasim-tang on chronic acid reflux esophagitis. World journal of gastroenterology 2017;23(25):4644-53. https://doi.org/10.3748/wjg.v23.i25.4644
  5. Wang Y, Wei W. Clinical Observation of Reflux Esophagitis Treated with Modified BanxiaXiexin Decoction and Rabeprazole. World Journal of Integrated Traditional and Western Medicine 2013;8(2):200-2.
  6. Kim YJ, Hwang BD. Factors affecting medicines expenditure costs-Using Korean medical panel data. Jour of Ko Con A 2018;18(4):664-76.
  7. Song KH. Functional dyspepsia. Korean Journal of Psychosomatic Medicine 2016;24(1):3-8.
  8. Oh JH, Kwon JG. Functional dyspepsia. The Korean Journal of Gastroenterology 2019;73(2):77-83. https://doi.org/10.4166/kjg.2019.73.2.77
  9. Baek KY, Kim SJ, Kim JB, Lee JH, Moon SO, Lee HD, et al. Comparison of marker components and biological activities of socheongryong-tang by different extract methods. Korean Journal of Pharmacognosy 2018;49(4):349-61.
  10. Lee SY, Choi SC, Cho YK, Choi MG. Validation of the Nepean dyspepsia index-Korean version. Kor J Neurogastroenterol Mot 2003;9(suppl):48S.
  11. Choi JY, Bae GE, Shim SH, Seo HJ, Seo HB, Choi JY, et al. Correlation study between electrogastrography and Nepean Dyspepsia Index (NDI) in clinical practice students. J Int Korean Med 2018;39(4):732-40. https://doi.org/10.22246/jikm.2018.39.4.732
  12. Lee OY. Gastrointestinal motility modulating drugs. Journal of the Korean Medical Association 2009;52(9):920-7. https://doi.org/10.5124/jkma.2009.52.9.920
  13. Stolfi C, De Simone V, Pallone F, Monteleone G. Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer. International journal of molecular sciences 2013;14(9):17972-85. https://doi.org/10.3390/ijms140917972
  14. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. The American journal of gastroenterology 1999;94(9):2390-7. https://doi.org/10.1016/S0002-9270(99)00419-0
  15. Arinton IG, Samudro P, Sutrisna E, Wibawa I. Randomized clinical trial of omeprazole and ranitidine using Indonesian translated Nepean Dyspepsia Index. J Intern Med 2006;7:170-7.
  16. Hashash JG, Abdul-Baki H, Azar C, Elhajj II, El Zahabi L, Chaar HF, et al. Clinical trial: a randomized controlled cross-over study of flupenthixol+ melitracen in functional dyspepsia. Alimentary pharmacology & therapeutics 2008;27(11):1148-55. https://doi.org/10.1111/j.1365-2036.2008.03677.x
  17. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Alimentary pharmacology & therapeutics 1999;13(2):225-35. https://doi.org/10.1046/j.1365-2036.1999.00445.x
  18. Shin HW, Chung SJ. Drug-induced parkinsonism. Journal of clinical neurology 2012;8(1):15-21. https://doi.org/10.3988/jcn.2012.8.1.15
  19. Shim YH, Park JY, Choi WW, Min IK, Park SU, Jung WS, et al. Herbal medicine treatment for drug-induced parkinsonism. The Journal of Alternative and Complementary Medicine 2015;21(5):273-80. https://doi.org/10.1089/acm.2014.0124
  20. Cho YK, Choi MG, Kim SH, Lee IS, Kim SW, Chung IS, et al. The effect of mosapride on quality of life in functional dyspepsia. The Korean journal of gastroenterology=Taehan Sohwagi Hakhoe chi 2004;43(3):160-7.
  21. Lee JW, Youn YH, Choi SC, Lee KJ, Kim NY. Multicenter, randomized, placebo-controlled trial to evaluate the efficacy and safety of a controlled-release, once-daily UIC201609/UIC201610 combination therapy for functional dyspepsia: Preliminary study. Korean J Gastroenterol 2021;77(4):171-8. https://doi.org/10.4166/kjg.2020.171